日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Autoantibodies as predictors for immune-related adverse events in checkpoint inhibition therapy of metastatic melanoma

自身抗体作为转移性黑色素瘤免疫检查点抑制剂治疗中免疫相关不良事件的预测因子

Reschke, Robin; Budde, Petra; Zucht, Hans-Dieter; Mangana, Johanna; Dummer, Reinhard; Pfoehler, Claudia; Wistuba-Hamprecht, Kilian; Weide, Benjamin; Hakim-Meibodi, Lara-Elena; Meier, Friedegund; Schulz, Carsten; Richter, Jasmin; Bräutigam, Manual; Gutjahr, Claudia; Schulz-Knappe, Peter; Hassel, Jessica C

Exploratory Analysis of Biomarkers and Treatment Outcomes from the COLUMBUS Study in BRAF V600E/K-Mutant Advanced or Metastatic Melanoma

对 BRAF V600E/K 突变型晚期或转移性黑色素瘤的 COLUMBUS 研究中生物标志物和治疗结果的探索性分析

Dummer, Reinhard; Deng, Shibing; Xie, Tao; Pathan, Nuzhat; Saffari, Hedieh; Robert, Caroline; Arance, Ana; de Groot, Jan Willem B; Garbe, Claus; Gogas, Helen J; Gutzmer, Ralf; Krajsová, Ivana; Liszkay, Gabriella; Loquai, Carmen; Mandala, Mario; Schadendorf, Dirk; Yamazaki, Naoya; Ascierto, Paolo A; Davis, Craig B; Shah, Khyati; Hamilton, Phineas; di Pietro, Alessandra; Flaherty, Keith

Plain language summary of the LOGIC 2 study: Encorafenib, binimetinib, plus a third drug for people with BRAF V600-mutant melanoma

LOGIC 2 研究的简明语言摘要:恩考拉非尼、比美替尼联合第三种药物治疗 BRAF V600 突变型黑色素瘤患者

Dummer, Reinhard; Sandhu, Shahneen; Miller, Wilson H Jr; Butler, Marcus O; Taylor, Matthew H; Heinzerling, Lucie; Blank, Christian U; Couselo, Eva Muñoz; Burris, Howard A 3rd; Postow, Michael A; Chmielowski, Bartosz; Middleton, Mark R; Berking, Carola; Hassel, Jessica C; Gesierich, Anja Heike; Mauch, Cornelia; Kleha, Joseph F; Polli, Anna; Harney, Allison S; di Pietro, Alessandra; Ascierto, Paolo A

Advantages of MelArray over Oncomine Focus Assay for Mutation Analysis in Melanoma

MelArray 相较于 Oncomine Focus Assay 在黑色素瘤突变分析中的优势

Quacoe, Andrew E; Freiberger, Sandra N; Levesque, Mitchell P; Dummer, Reinhard; Ramelyte, Egle

Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma

晚期黑色素瘤患者接受纳武利尤单抗联合伊匹木单抗治疗的最终10年疗效

Wolchok, Jedd D; Chiarion-Sileni, Vanna; Rutkowski, Piotr; Cowey, C Lance; Schadendorf, Dirk; Wagstaff, John; Queirolo, Paola; Dummer, Reinhard; Butler, Marcus O; Hill, Andrew G; Postow, Michael A; Gaudy-Marqueste, Caroline; Medina, Theresa; Lao, Christopher D; Walker, John; Márquez-Rodas, Iván; Haanen, John B A G; Guidoboni, Massimo; Maio, Michele; Schöffski, Patrick; Carlino, Matteo S; Sandhu, Shahneen; Lebbé, Céleste; Ascierto, Paolo A; Long, Georgina V; Ritchings, Corey; Nassar, Ayman; Askelson, Margarita; Benito, Melanie Pe; Wang, Wenjia; Hodi, F Stephen; Larkin, James

Neoadjuvant anti-PD-1 alone or in combination with anti-TIGIT or an oncolytic virus in resectable stage IIIB-D melanoma: a phase 1/2 trial

新辅助抗PD-1单药治疗或联合抗TIGIT或溶瘤病毒治疗可切除的IIIB-D期黑色素瘤:一项1/2期试验

Dummer, Reinhard; Robert, Caroline; Scolyer, Richard A; Taube, Janis M; Tetzlaff, Michael T; Menzies, Alexander M; Hill, Andrew; Grob, Jean-Jacques; Portnoy, David C; Lebbe, Celeste; Khattak, Muhammad A; Cohen, Jonathan; Bar-Sela, Gil; Mehmi, Inderjit; Shapira-Frommer, Ronnie; Meyer, Nicolas; Webber, Andrea L; Ren, Yixin; Fukunaga-Kalabis, Mizuho; Krepler, Clemens; Long, Georgina V

Publisher Correction: Feasibility of multiomics tumor profiling for guiding treatment of melanoma

出版商更正:多组学肿瘤分析指导黑色素瘤治疗的可行性

Miglino, Nicola; Toussaint, Nora C; Ring, Alexander; Bonilla, Ximena; Tusup, Marina; Gosztonyi, Benedict; Mehra, Tarun; Gut, Gabriele; Jacob, Francis; Chevrier, Stephane; Lehmann, Kjong-Van; Casanova, Ruben; Jacobs, Andrea; Sivapatham, Sujana; Boos, Laura; Rahimzadeh, Parisa; Schuerch, Manuel; Sobottka, Bettina; Chicherova, Natalia; Yu, Shuqing; Wegmann, Rebekka; Mena, Julien; Milani, Emanuela S; Goetze, Sandra; Esposito, Cinzia; Sarabia Del Castillo, Jacobo; Frei, Anja L; Nowak, Marta; Irmisch, Anja; Kuipers, Jack; Baciu-Drăgan, Monica-Andreea; Ferreira, Pedro F; Singer, Franziska; Bertolini, Anne; Prummer, Michael; Lischetti, Ulrike; Aebersold, Rudolf; Bacac, Marina; Maass, Gerd; Moch, Holger; Weller, Michael; Theocharides, Alexandre P A; Manz, Markus G; Beerenwinkel, Niko; Beisel, Christian; Pelkmans, Lucas; Snijder, Berend; Wollscheid, Bernd; Heinzelmann, Viola; Bodenmiller, Bernd; Levesque, Mitchell P; Koelzer, Viktor H; Rätsch, Gunnar; Dummer, Reinhard; Wicki, Andreas

Adjuvant nivolumab and relatlimab in stage III/IV melanoma: the randomized phase 3 RELATIVITY-098 trial

辅助性纳武利尤单抗和瑞拉利单抗治疗 III/IV 期黑色素瘤:随机 3 期 RELATIVITY-098 试验

Long, Georgina V; Garnett-Benson, Charlie; Dolfi, Sonia; Ascierto, Paolo A; Guo, Jun; Tarhini, Ahmad A; Chandra, Sunandana; Muñoz-Couselo, Eva; Del Vecchio, Michele; de Melo, Andreia Cristina; Callahan, Margaret; Gogas, Helen; Dummer, Reinhard; Schadendorf, Dirk; Koelblinger, Peter; Quereux, Gaelle; Thomas, Ioannis; Yu, Jia Xin; Fisher, Andrew; Wang, Bonnie; Djidel, Patrick; Chouzy, Armand; Semaan, Mark; Chen, Bohang; Cheong, Alicia M Y; Tawbi, Hussein A

Feasibility of multiomics tumor profiling for guiding treatment of melanoma

多组学肿瘤分析指导黑色素瘤治疗的可行性

Miglino, Nicola; Toussaint, Nora C; Ring, Alexander; Bonilla, Ximena; Tusup, Marina; Gosztonyi, Benedict; Mehra, Tarun; Gut, Gabriele; Jacob, Francis; Chevrier, Stephane; Lehmann, Kjong-Van; Casanova, Ruben; Jacobs, Andrea; Sivapatham, Sujana; Boos, Laura; Rahimzadeh, Parisa; Schuerch, Manuel; Sobottka, Bettina; Chicherova, Natalia; Yu, Shuqing; Wegmann, Rebekka; Mena, Julien; Milani, Emanuela S; Goetze, Sandra; Esposito, Cinzia; Sarabia Del Castillo, Jacobo; Frei, Anja L; Nowak, Marta; Irmisch, Anja; Kuipers, Jack; Baciu-Drăgan, Monica-Andreea; Ferreira, Pedro F; Singer, Franziska; Bertolini, Anne; Prummer, Michael; Lischetti, Ulrike; Aebersold, Rudolf; Bacac, Marina; Maass, Gerd; Moch, Holger; Weller, Michael; Theocharides, Alexandre P A; Manz, Markus G; Beerenwinkel, Niko; Beisel, Christian; Pelkmans, Lucas; Snijder, Berend; Wollscheid, Bernd; Heinzelmann, Viola; Bodenmiller, Bernd; Levesque, Mitchell P; Koelzer, Viktor H; Rätsch, Gunnar; Dummer, Reinhard; Wicki, Andreas

Author Correction: Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours

作者更正:中和 GDF-15 可以克服实体瘤中的抗 PD-1 和抗 PD-L1 耐药性

Melero, Ignacio; de Miguel Luken, Maria; de Velasco, Guillermo; Garralda, Elena; Martín-Liberal, Juan; Joerger, Markus; Alonso, Guzman; Goebeler, Maria-Elisabeth; Schuler, Martin; König, David; Dummer, Reinhard; Reig, Maria; Rodriguez Ruiz, Maria-Esperanza; Calvo, Emiliano; Esteban-Villarrubia, Jorge; Oberoi, Arjun; Sabat, Paula; Soto-Castillo, Juan José; Koster, Kira-Lee; Saavedra, Omar; Sayehli, Cyrus; Gromke, Tanja; Läubli, Heinz; Ramelyte, Egle; Fortuny, Marta; Landa-Magdalena, Ana; Moreno, Irene; Torres-Jiménez, Javier; Hernando-Calvo, Alberto; Hess, Dagmar; Racca, Fabricio; Richly, Heike; Schmitt, Andreas M; Eggenschwiler, Corinne; Sanduzzi-Zamparelli, Marco; Vilalta-Lacarra, Anna; Trojan, Jörg; Koch, Christine; Galle, Peter R; Foerster, Friedrich; Trajanoski, Zlatko; Hackl, Hubert; Gogolla, Falk; Koll, Florestan J; Wild, Peter; Chun, Felix Kyoung Hwan; Reis, Henning; Lloyd, Peter; Machacek, Matthias; Gajewski, Thomas F; Fridman, Wolf H; Eggermont, Alexander M M; Bargou, Ralf; Schöniger, Sandra; Rüschoff, Josef; Tereshchenko, Anastasiia; Zink, Carina; da Silva, Antonio; Lichtenegger, Felix S; Akdemir, Julia; Rüdiger, Manfred; L'Huillier, Phil; Dutta, Aradhana; Haake, Markus; Auckenthaler, Alexandra; Gjorgjioska, Ana; Rössler, Bernhard; Hermann, Frank; Liebig, Mara; Reichhardt, Daniela; Schuberth-Wagner, Christine; Wischhusen, Jörg; Fettes, Petra; Auer, Marlene; Klar, Kathrin; Leo, Eugen